Beyond the 24-hour window: Timing-dependent effectiveness of dual antiplatelet therapy in minor stroke and high-risk TIA

Key Points

• Improved vascular outcomes is linked to timely administration of dual antiplatelet therapy.
• Data shows therapy effectiveness increases significantly when initiated within specific timeframes.
• Observational analysis examines cases of minor stroke and transient ischemic attack in diverse settings.
• Findings indicate timing is crucial in maximizing benefits of dual antiplatelet treatment for patients.